These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 33945675)

  • 1. Lipocalin 2 regulates iron homeostasis, neuroinflammation, and insulin resistance in the brains of patients with dementia: Evidence from the current literature.
    Lim D; Jeong JH; Song J
    CNS Neurosci Ther; 2021 Aug; 27(8):883-894. PubMed ID: 33945675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging insights into Lipocalin-2: Unraveling its role in Parkinson's Disease.
    Qiu R; Cai Y; Su Y; Fan K; Sun Z; Zhang Y
    Biomed Pharmacother; 2024 Aug; 177():116947. PubMed ID: 38901198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin 2 as a Putative Modulator of Local Inflammatory Processes in the Spinal Cord and Component of Organ Cross talk After Spinal Cord Injury.
    Behrens V; Voelz C; Müller N; Zhao W; Gasterich N; Clarner T; Beyer C; Zendedel A
    Mol Neurobiol; 2021 Nov; 58(11):5907-5919. PubMed ID: 34417948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation.
    Xiao X; Yeoh BS; Vijay-Kumar M
    Annu Rev Nutr; 2017 Aug; 37():103-130. PubMed ID: 28628361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Progress on Lipocalin-2 in Diabetic Encephalopathy.
    Zhang W; Chen S; Zhuang X
    Neuroscience; 2023 Apr; 515():74-82. PubMed ID: 36805002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of lipocalin 2 in stroke.
    Zhao RY; Wei PJ; Sun X; Zhang DH; He QY; Liu J; Chang JL; Yang Y; Guo ZN
    Neurobiol Dis; 2023 Apr; 179():106044. PubMed ID: 36804285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipocalin 2 alleviates iron toxicity by facilitating hypoferremia of inflammation and limiting catalytic iron generation.
    Xiao X; Yeoh BS; Saha P; Olvera RA; Singh V; Vijay-Kumar M
    Biometals; 2016 Jun; 29(3):451-65. PubMed ID: 27007712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive review of lipocalin 2-mediated effects in lung inflammation.
    Guardado S; Ojeda-Juárez D; Kaul M; Nordgren TM
    Am J Physiol Lung Cell Mol Physiol; 2021 Oct; 321(4):L726-L733. PubMed ID: 34468208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis.
    Jung BK; Ryu KY
    Exp Mol Med; 2023 Oct; 55(10):2138-2146. PubMed ID: 37779143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical role of lipocalin-2 in metabolic disorders and neurological complications.
    Bhusal A; Rahman MH; Lee WH; Bae YC; Lee IK; Suk K
    Biochem Pharmacol; 2019 Nov; 169():113626. PubMed ID: 31476294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases.
    Dekens DW; Eisel ULM; Gouweleeuw L; Schoemaker RG; De Deyn PP; Naudé PJW
    Ageing Res Rev; 2021 Sep; 70():101414. PubMed ID: 34325073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Responses of Astrocytes Are Independent from Lipocalin 2.
    Gasterich N; Wetz S; Tillmann S; Fein L; Seifert A; Slowik A; Weiskirchen R; Zendedel A; Ludwig A; Koschmieder S; Beyer C; Clarner T
    J Mol Neurosci; 2021 May; 71(5):933-942. PubMed ID: 32959226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sailuotong Capsule Prevents the Cerebral Ischaemia-Induced Neuroinflammation and Impairment of Recognition Memory through Inhibition of LCN2 Expression.
    Zhang Y; Liu J; Yao M; Song W; Zheng Y; Xu L; Sun M; Yang B; Bensoussan A; Chang D; Li H
    Oxid Med Cell Longev; 2019; 2019():8416105. PubMed ID: 31565154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-specific metabolic functions of adipose Lipocalin-2.
    Chella Krishnan K; Sabir S; Shum M; Meng Y; Acín-Pérez R; Lang JM; Floyd RR; Vergnes L; Seldin MM; Fuqua BK; Jayasekera DW; Nand SK; Anum DC; Pan C; Stiles L; Péterfy M; Reue K; Liesa M; Lusis AJ
    Mol Metab; 2019 Dec; 30():30-47. PubMed ID: 31767179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipocalin-2 as a therapeutic target for brain injury: An astrocentric perspective.
    Suk K
    Prog Neurobiol; 2016 Sep; 144():158-72. PubMed ID: 27498195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lipocalin 2 in intraventricular haemoglobin-induced brain injury.
    Shishido H; Toyota Y; Hua Y; Keep RF; Xi G
    Stroke Vasc Neurol; 2016 Jun; 1(2):37-43. PubMed ID: 28959462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions and regulation of lipocalin-2 in gut-origin sepsis: a narrative review.
    Lu F; Inoue K; Kato J; Minamishima S; Morisaki H
    Crit Care; 2019 Aug; 23(1):269. PubMed ID: 31375129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipocalin-2 in Diabetic Complications of the Nervous System: Physiology, Pathology, and Beyond.
    Bhusal A; Lee WH; Suk K
    Front Physiol; 2021; 12():638112. PubMed ID: 33613327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipocalin-2 inhibits autophagy and induces insulin resistance in H9c2 cells.
    Chan YK; Sung HK; Jahng JW; Kim GH; Han M; Sweeney G
    Mol Cell Endocrinol; 2016 Jul; 430():68-76. PubMed ID: 27090568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System.
    Kim BW; Jeong KH; Kim JH; Jin M; Kim JH; Lee MG; Choi DK; Won SY; McLean C; Jeon MT; Lee HW; Kim SR; Suk K
    J Neurosci; 2016 May; 36(20):5608-22. PubMed ID: 27194339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.